Abstract:According to WHO, cancer is the cause of ~5 million deaths annually. To date, there is no universal solution to fight cancer despite outstanding achievements of radiotherapy, chemotherapy, and immunotherapy. In this regard, there is a need to develop new approaches to antitumor therapy, in particular based on the search and use of targeted molecules that allow killing tumor cells of various types with high efficiency without significant toxic effects on healthy organs and tissues. This review presents the characteristics of the main proteins of the heat shock proteins (HSP) family, the features of their expression in tumor cells, and the possibility of using monoclonal antibodies against these proteins as a guiding vector for antitumor immunotherapy.

What problem does this paper attempt to address?

The main purpose of this paper is to summarize the research progress of heat shock proteins (HSPs) as targets for anti-tumor therapy and to explore their potential applications in targeted delivery of anti-tumor drugs. Specifically, the paper first introduces the challenges faced in cancer treatment, emphasizing the importance of finding new anti-tumor therapies. Subsequently, the article focuses on the functions of the heat shock protein family members, their abnormal expression in tumor cells, and how these proteins can become potential tumor markers. The core content of the paper includes the following aspects: 1. **Functions of Heat Shock Proteins**: HSPs primarily act as molecular chaperones involved in the correct folding of newly synthesized proteins, their transport, and the formation of protein complexes, thereby maintaining intracellular protein homeostasis. 2. **Heat Shock Proteins as Tumor Markers**: The presence of HSPs has been found on the surface of many types of cancer cells, making them potential tumor-specific markers. 3. **Translocation of Heat Shock Protein 70 (HSP70) to the Cell Surface**: Studies have found that HSP70 can be transferred to the cell membrane surface through a non-classical secretion pathway, a phenomenon related to the occurrence and development of tumors. 4. **Targeted Drug Delivery Using Antibodies Against Heat Shock Proteins**: By using monoclonal antibodies against HSP70, anti-cancer drugs can be precisely delivered to tumor cells expressing these proteins, improving therapeutic efficacy and reducing damage to healthy tissues. 5. **Anti-Tumor Mechanisms of Antibodies Targeting Heat Shock Proteins**: The study explored the mechanisms of antibody-mediated cytotoxicity and the activation of the immune system to fight against tumor cells. In summary, this paper aims to summarize the application prospects of heat shock proteins in tumor therapy, particularly their potential as drug delivery carriers, and the enhancement of anti-tumor activity of the immune system through antibodies targeting these proteins.

Heat Shock Proteins on Tumor Cell Surface as Target for Anti-Tumor Therapy (A Review)

Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach

Immunotherapy: A New Target for Cancer Cure (Review)

Recent Advances in Heat Shock Protein-Based Cancer Vaccines

Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer

Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives

The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics

Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy

Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials

Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment

Mechanisms of Action of HSP110 and Its Cognate Family Members in Carcinogenesis

HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)

Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential

The multifunction of HSP70 in cancer: Guardian or traitor to the survival of tumor cells and the next potential therapeutic target

Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments

Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches

Membrane heat shock protein 70: a theranostic target for cancer therapy

Towards a Better Way to Die with Chemotherapy: Role of Heat Shock Protein Exposure on Dying Tumor Cells

Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years